The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.
- DOI
- 10.1177/17562848261446551
- Published
- 2026
- Container
- Therapeutic advances in gastroenterology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/17562848261446551,
title = {The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.},
author = {Bodger K and Booker C and Taylor F and Ahmad T and Bloom S and Butterworth J and VEST Study Group and Kok K and Lobo A and Irving P and Cummings JRF},
year = {2026},
journal = {Therapeutic advances in gastroenterology},
doi = {10.1177/17562848261446551},
url = {https://doi.org/10.1177/17562848261446551}
}RIS
TY - JOUR TI - The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes. AU - Bodger K AU - Booker C AU - Taylor F AU - Ahmad T AU - Bloom S AU - Butterworth J AU - VEST Study Group AU - Kok K AU - Lobo A AU - Irving P AU - Cummings JRF PY - 2026 JO - Therapeutic advances in gastroenterology DO - 10.1177/17562848261446551 UR - https://doi.org/10.1177/17562848261446551 ER -
APA
K, B., C, B., F, T., T, A., S, B., J, B., Group, V. S., K, K., A, L., P, I., & JRF, C. (2026). The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.. Therapeutic advances in gastroenterology. https://doi.org/10.1177/17562848261446551
Source records
- pubmed · retrieved 2026-09-26T04:26:03.922Z